Home>>(±)14(15)-DiHET-d11

(±)14(15)-DiHET-d11 (Synonyms: (±)14,15-DiHETrE-d11)

Catalog No.GC46258

A neuropeptide with diverse biological activities

Products are for research use only. Not for human use. We do not sell to patients.

(±)14(15)-DiHET-d11 Chemical Structure

Cas No.: N/A

Size Price Stock Qty
25 μg
$253.00
In stock
50 μg
$482.00
In stock
100 μg
$914.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

(±)14(15)-DiHET-d11 contains 11 deuterium atoms at the 16, 16, 17, 17, 18, 18, 19, 19, 20, 20, and 20 positions. It is intended for use as an internal standard for the quantification of (±)14(15)-DiHET by GC- or LC-mass spectrometry. Epoxide hydrolases convert the EETs into vicinal diols, with the concurrent loss of much of their biological activity.1 (±)14(15)-DiHET is the urinary metabolite of (±)14(15)-EET which has been documented by GC-MS to be elevated in pregnancy-induced hypertension.2

1.Oliw, E.H., Guengerich, F.P., and Oates, J.A.Oxygenation of arachidonic acid by hepatic monooxygenases. Isolation and metabolism of four epoxide intermediatesJ. Biol. Chem.257(7)3771-3781(1982) 2.Catella, F., Lawson, J.A., Fitzgerald, D.J., et al.Endogenous biosynthesis of arachidonic acid epoxides in humans: Increased formation in pregnancy-induced hypertensionProc. Natl. Acad. Sci. U.S.A.87(15)5893-5897(1990)

Reviews

Review for (±)14(15)-DiHET-d11

Average Rating: 5 ★★★★★ (Based on Reviews and 24 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for (±)14(15)-DiHET-d11

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.